CONMEDCNMD
CNMD
About: Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.
Employees: 3,900
0
Funds holding %
of 7,419 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
731% more call options, than puts
Call options by funds: $8.3M | Put options by funds: $999K
5.99% more ownership
Funds ownership: 109.77% [Q3] → 115.76% (+5.99%) [Q4]
0% more capital invested
Capital invested by funds: $2.43B [Q3] → $2.44B (+$8.62M) [Q4]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]
2% less repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 98
10% less first-time investments, than exits
New positions opened: 38 | Existing positions closed: 42
4% less funds holding
Funds holding: 286 [Q3] → 275 (-11) [Q4]
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$70
47%
upside
Avg. target
$77
61%
upside
High target
$91
91%
upside
4 analyst ratings
2 positive
50%
2 neutral
50%
0 negative
0%
Stifel Rick Wise 24% 1-year accuracy 8 / 34 met price target | 57%upside $75 | Buy Maintained | 6 Feb 2025 |
Wells Fargo Vik Chopra 27% 1-year accuracy 3 / 11 met price target | 47%upside $70 | Equal-Weight Maintained | 6 Feb 2025 |
Needham Mike Matson 22% 1-year accuracy 27 / 121 met price target | 91%upside $91 | Buy Maintained | 6 Feb 2025 |
JP Morgan Robbie Marcus 30% 1-year accuracy 6 / 20 met price target | 47%upside $70 | Neutral Downgraded | 6 Feb 2025 |
Financial journalist opinion
Based on 3 articles about CNMD published over the past 30 days
Positive
Zacks Investment Research
1 week ago
4 Stocks to Watch as Dental Supplies Recovers Amid Tariff Headwind
Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These are CAH, MMSI, XRAY and CNMD.
Neutral
Zacks Investment Research
1 week ago
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
CNMD is poised for growth on the back of strong product offerings and recurring revenues but faces headwinds from regulatory challenges, supply-chain constraints and cybersecurity risks.
Neutral
Business Wire
2 weeks ago
CONMED Corporation to Announce First Quarter 2025 Financial Results on April 30, 2025
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2025 after the market close on Wednesday, April 30, 2025. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed fro.
Neutral
Business Wire
1 month ago
CONMED Corporation Adds Mark Kaye to its Board of Directors
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Mark Kaye will be joining its Board of Directors effective February 24th, 2025. “My fellow directors and I are extremely pleased to welcome Mark to the board,” said Martha Goldberg Aronson, Chair of CONMED's Board of Directors. “Mark brings a wealth of experience to CONMED, including deep knowledge across finance, accounting, risk management, strategic planning, and operational efficiencies. He also brings a stro.
Neutral
Business Wire
1 month ago
CONMED Corporation Announces Quarterly Cash Dividend
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on February 24, 2025, payable on April 4, 2025, to all shareholders of record as of March 14, 2025. About CONMED Corporation CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties, includ.
Negative
Zacks Investment Research
2 months ago
New Strong Sell Stocks for February 19th
ACDVF, BN and CNMD have been added to the Zacks Rank #5 (Strong Sell) List on February 19, 2024.
Negative
Zacks Investment Research
2 months ago
New Strong Sell Stocks for February 11th
ATS, CNMD and CSX have been added to the Zacks Rank #5 (Strong Sell) List on February 11, 2025.
Neutral
Zacks Investment Research
2 months ago
CNMD's Q4 Earnings & Sales Beat Estimates, Stock Down on Weak Outlook
CONMED reports solid fourth-quarter results, fueled by strength in the General Surgery segment and continued demand for AirSeal product.
Negative
Benzinga
2 months ago
These Analysts Slash Their Forecasts On Conmed After Q4 Results
CONMED Corporation CNMD posted better-than-expected earnings for its fourth quarter, but issued FY25 earnings and revenue guidance below estimates.
Positive
Zacks Investment Research
2 months ago
Here's What Key Metrics Tell Us About Conmed (CNMD) Q4 Earnings
Although the revenue and EPS for Conmed (CNMD) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Charts implemented using Lightweight Charts™